Liquid Biopsy: It's the Bloody Truth!

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Liquid biopsy is a promising clinical tool that can provide critical information for prognostication and which may inform treatment decisions in men with metastatic castration-resistant prostate cancer. Here we discuss the Foundation Medicine plasma cell-free circulating tumor DNA assay, its pros and cons, and potential clinical utility.See related article by Tukachinsky et al., p. 3094.

Keyphrases

circulating tumor
cell free
ultrasound guided
circulating tumor cells
fine needle aspiration
ionic liquid
small cell lung cancer
squamous cell carcinoma
high throughput
healthcare
middle aged
risk assessment
combination therapy
human health
health information
climate change